Occludin is a direct target of thyroid transcription factor-1 (TTF-1/NKX2-1)

Journal of Biological Chemistry

Volumn 287, Issue 34, 2012, Pages 28790-28801

  Runkle, E Aaron ^a,e   Rice, Shawn J ^a   Qi, Ji ^a   Masser, Dustin ^a   Antonetti, David A ^c   Winslow, Monte M ^d   Mu, David ^a,b  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

^b PENN STATE CANCER INSTITUTE   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

^d STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL MODEL; ANOIKIS; CELL-BASED; CELLULAR CONTEXTS; CELLULAR SENSITIVITY; CRITICAL FACTORS; DIRECT INTERACTIONS; EPITHELIAL TO MESENCHYMAL TRANSITIONS; HUMAN LUNG CANCER CELLS; INHIBITORY EFFECT; LUNG CANCER; LUNG CARCINOMA; LUNG DEVELOPMENT; MOUSE MODELS; OCCLUDIN; OVER-EXPRESSION; TIGHT JUNCTIONS; TRANSCRIPTIONAL ACTIVATIONS; TUMOR SUPPRESSORS;

CELLS; CYTOLOGY; DISEASES; GENES; GENETIC ENGINEERING; PATHOLOGY; TRANSCRIPTION FACTORS;

BIOLOGICAL ORGANS;

CLAUDIN 1; OCCLUDIN; SMALL INTERFERING RNA; THYROID TRANSCRIPTION FACTOR 1; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANOIKIS; ARTICLE; CANCER CELL; CANCER INHIBITION; CANCER RESISTANCE; CELL ACTIVITY; CELL MIGRATION; CLAUDIN 1 GENE; DOWN REGULATION; GENE; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENE SILENCING; LUNG ADENOCARCINOMA; METASTASIS; MOUSE; NONHUMAN; OCCLUDIN GENE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; RNA INTERFERENCE; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION;

ADENOCARCINOMA; ANIMALS; ANOIKIS; CELL LINE, TUMOR; CELL MOVEMENT; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HUMANS; LUNG NEOPLASMS; MEMBRANE PROTEINS; MICE; NEOPLASM METASTASIS; NEOPLASMS, EXPERIMENTAL; NUCLEAR PROTEINS; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TUMOR SUPPRESSOR PROTEINS;

EID: 84865262164     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M112.367987     Document Type: Article

References (59)

1. Maeda, Y., Davé, V., and Whitsett, J. A. (2007) Transcriptional control of lung morphogenesis. Physiol. Rev. 87, 219-244
2. Briscoe, J., Pierani, A., Jessell, T. M., and Ericson, J. (2000) A homeodomain protein code specifies progenitor cell identity and neuronal fate in the ventral neural tube. Cell 101, 435-445
3. Kendall, J., Liu, Q., Bakleh, A., Krasnitz, A., Nguyen, K. C., Lakshmi, B., Gerald, W. L., Powers, S., and Mu, D. (2007) Oncogenic cooperation and coamplification of developmental transcription factor genes in lung cancer. Proc. Natl. Acad. Sci. U.S.A. 104, 16663-16668 (Pubitemid 350211073)
4. Kwei, K. A., Kim, Y. H., Girard, L., Kao, J., Pacyna-Gengelbach, M., Salari, K., Lee, J., Choi, Y. L., Sato, M., Wang, P., Hernandez-Boussard, T., Gazdar, A. F., Petersen, I., Minna, J. D., and Pollack, J. R. (2008) Genomic profiling identifies TITF1 as a lineage-specific oncogene amplified in lung cancer. Oncogene 27, 3635-3640 (Pubitemid 351793793)
5. Tanaka, H., Yanagisawa, K., Shinjo, K., Taguchi, A., Maeno, K., Tomida, S., Shimada, Y., Osada, H., Kosaka, T., Matsubara, H., Mitsudomi, T., Sekido, Y., Tanimoto, M., Yatabe, Y., and Takahashi, T. (2007) Lineage-specific dependency of lung adenocarcinomas on the lung development regulator TTF-1. Cancer Res. 67, 6007-6011 (Pubitemid 47037477)
6. Weir, B. A., Woo, M. S., Getz, G., Perner, S., Ding, L., Beroukhim, R., Lin, W. M., Province, M. A., Kraja, A., Johnson, L. A., Shah, K., Sato, M., Thomas, R. K., Barletta, J. A., Borecki, I. B., Broderick, S., Chang, A. C., Chiang, D. Y., Chirieac, L. R., Cho, J., Fujii, Y., Gazdar, A. F., Giordano, T., Greulich, H., Hanna, M., Johnson, B. E., Kris, M. G., Lash, A., Lin, L., Lindeman, N., Mardis, E. R., McPherson, J. D., Minna, J. D., Morgan, M. B., Nadel, M., Orringer, M. B., Osborne, J. R., Ozenberger, B., Ramos, A. H., Robinson, J., Roth, J. A., Rusch, V., Sasaki, H., Shepherd, F., Sougnez, C., Spitz, M. R., Tsao, M. S., Twomey, D., Verhaak, R. G., Weinstock, G. M., Wheeler, D. A., Winckler, W., Yoshizawa, A., Yu, S., Zakowski, M. F., Zhang, Q., Beer, D. G., Wistuba, II, Watson, M. A., Garraway, L. A., Ladanyi, M., Travis, W. D., Pao, W., Rubin, M. A., Gabriel, S. B., Gibbs, R. A., Varmus, H. E., Wilson, R. K., Lander, E. S., and Meyerson, M. (2007) Characterizing the cancer genome in lung adenocarcinoma. Nature 450, 893-898 (Pubitemid 350231325)
7. Taguchi, A., Politi, K., Pitteri, S. J., Lockwood, W. W., Faça, V. M., Kelly-Spratt, K., Wong, C. H., Zhang, Q., Chin, A., Park, K. S., Goodman, G., Gazdar, A. F., Sage, J., Dinulescu, D. M., Kucherlapati, R., Depinho, R. A., Kemp, C. J., Varmus, H. E., and Hanash, S. M. (2011) Lung cancer signatures in plasma based on proteome profiling of mouse tumor models. Cancer cell 20, 289-299
8. Homminga, I., Pieters, R., Langerak, A. W., de Rooi, J. J., Stubbs, A., Verstegen, M., Vuerhard, M., Buijs-Gladdines, J., Kooi, C., Klous, P., van Vlierberghe, P., Ferrando, A. A., Cayuela, J. M., Verhaaf, B., Beverloo, H. B., Horstmann, M., de Haas, V., Wiekmeijer, A. S., Pike-Overzet, K., Staal, F. J., de Laat, W., Soulier, J., Sigaux, F., and Meijerink, J. P. (2011) Integrated transcript and genome analyses reveal NKX2-1 and MEF2C as potential oncogenes in T cell acute lymphoblastic leukemia. Cancer cell 19, 484-497
9. Yamaguchi, T., Yanagisawa, K., Sugiyama, R., Hosono, Y., Shimada, Y., Arima, C., Kato, S., Tomida, S., Suzuki, M., Osada, H., and Takahashi, T. (2012) NKX2-1/TITF1/TTF-1-induced ROR1 is required to sustain EGFR survival signaling in lung adenocarcinoma. Cancer Cell 21, 348-361
10. Anagnostou, V. K., Syrigos, K. N., Bepler, G., Homer, R. J., and Rimm, D. L. (2009) Thyroid transcription factor 1 is an independent prognostic factor for patients with stage I lung adenocarcinoma. J. Clin. Oncol. 27, 271-278
11. Barletta, J. A., Perner, S., Iafrate, A. J., Yeap, B. Y., Weir, B. A., Johnson, L. A., Johnson, B. E., Meyerson, M., Rubin, M. A., Travis, W. D., Loda, M., and Chirieac, L. R. (2009) Clinical significance of TTF-1 protein expression and TTF-1 gene amplification in lung adenocarcinoma. J. Cell. Mol. Med. 13, 1977-1986
12. Berghmans, T., Paesmans, M., Mascaux, C., Martin, B., Meert, A. P., Haller, A., Lafitte, J. J., and Sculier, J. P. (2006) Thyroid transcription factor 1. A new prognostic factor in lung cancer. A meta-analysis. Ann. Oncol. 17, 1673-1676 (Pubitemid 44680888)
13. Tang, X., Kadara, H., Behrens, C., Liu, D. D., Xiao, Y., Rice, D., Gazdar, A. F., Fujimoto, J., Moran, C., Varella-Garcia, M., Lee, J. J., Hong, W. K., and Wistuba, I. I. (2011) Abnormalities of the TITF-1 lineage-specific oncogene in NSCLC. Implications in lung cancer pathogenesis and prognosis. Clin. Cancer Res. 17, 2434-2443
14. Saito, R. A., Watabe, T., Horiguchi, K., Kohyama, T., Saitoh, M., Nagase, T., and Miyazono, K. (2009) Thyroid transcription factor-1 inhibits transforming growth factor-β-mediated epithelial-to-mesenchymal transition in lung adenocarcinoma cells. Cancer Res. 69, 2783-2791
15. Winslow, M. M., Dayton, T. L., Verhaak, R. G., Kim-Kiselak, C., Snyder, E. L., Feldser, D. M., Hubbard, D. D., DuPage, M. J., Whittaker, C. A., Hoersch, S., Yoon, S., Crowley, D., Bronson, R. T., Chiang, D. Y., Meyerson, M., and Jacks, T. (2011) Suppression of lung adenocarcinoma progression by Nkx2-1. Nature 473, 101-104
16. Harris, T., Pan, Q., Sironi, J., Lutz, D., Tian, J., Sapkar, J., Perez-Soler, R., Keller, S., and Locker, J. (2011) Both gene amplification and allelic loss occur at 14q13.3 in lung cancer. Clin. Cancer Res. 17, 690-699
17. Tsukita, S., Yamazaki, Y., Katsuno, T., and Tamura, A. (2008) Tight junction-based epithelial microenvironment and cell proliferation. Oncogene 27, 6930-6938
18. Schulzke, J. D., Gitter, A. H., Mankertz, J., Spiegel, S., Seidler, U., Amasheh, S., Saitou, M., Tsukita, S., and Fromm, M. (2005) Epithelial transport and barrier function in occludin-deficient mice. Biochim. Biophys. Acta 1669, 34-42 (Pubitemid 40544519)
19. Phillips, B. E., Cancel, L., Tarbell, J. M., and Antonetti, D. A. (2008) Occludin independently regulates permeability under hydrostatic pressure and cell division in retinal pigment epithelial cells. Invest. Ophthalmol. Vis. Sci. 49, 2568-2576
20. Runkle, E. A., Sundstrom, J. M., Runkle, K. B., Liu, X., and Antonetti, D. A. (2011) Occludin localizes to centrosomes and modifies mitotic entry. J. Biol. Chem. 286, 30847-30858
21. Du, D., Xu, F., Yu, L., Zhang, C., Lu, X., Yuan, H., Huang, Q., Zhang, F., Bao, H., Jia, L., Wu, X., Zhu, X., Zhang, X., Zhang, Z., and Chen, Z. (2010) The tight junction protein, occludin, regulates the directional migration of epithelial cells. Dev. Cell 18, 52-63
22. Wang, Z., Wade, P., Mandell, K. J., Akyildiz, A., Parkos, C. A., Mrsny, R. J., and Nusrat, A. (2007) Raf 1 represses expression of the tight junction protein occludin via activation of the zinc finger transcription factor slug. Oncogene 26, 1222-1230
23. Li, D., and Mrsny, R. J. (2000) Oncogenic Raf-1 disrupts epithelial tight junctions via down-regulation of occludin. J. Cell Biol. 148, 791-800
24. Osanai, M., Murata, M., Nishikiori, N., Chiba, H., Kojima, T., and Sawada, N. (2006) Epigenetic silencing of occludin promotes tumorigenic and metastatic properties of cancer cells via modulations of unique sets of apoptosis-associated genes. Cancer Res. 66, 9125-9133 (Pubitemid 44521132)
25. Morin, P. J. (2005) Claudin proteins in human cancer. Promising new targets for diagnosis and therapy. Cancer Res. 65, 9603-9606
26. Singh, A. B., Sharma, A., and Dhawan, P. (2010) Claudin family of proteins and cancer. An overview. J. Oncol. 2010, 541957
27. Dhawan, P., Singh, A. B., Deane, N. G., No, Y., Shiou, S. R., Schmidt, C., Neff, J., Washington, M. K., and Beauchamp, R. D. (2005) Claudin-1 regulates cellular transformation and metastatic behavior in colon cancer. J. Clin. Invest. 115, 1765-1776 (Pubitemid 40979715)
28. Paschoud, S., Bongiovanni, M., Pache, J. C., and Citi, S. (2007) Claudin-1 and claudin-5 expression patterns differentiate lung squamous cell carcinomas from adenocarcinomas. Mod. Pathol. 20, 947-954 (Pubitemid 47267821)
29. Chao, Y. C., Pan, S. H., Yang, S. C., Yu, S. L., Che, T. F., Lin, C. W., Tsai, M. S., Chang, G. C., Wu, C. H., Wu, Y. Y., Lee, Y. C., Hong, T. M., and Yang, P. C. (2009) Claudin-1 is a metastasis suppressor and correlates with clinical outcome in lung adenocarcinoma. Am. J. Respir. Crit. Care Med. 179, 123-133
30. Rangel, L. B., Agarwal, R., D'Souza, T., Pizer, E. S., Alò, P. L., Lancaster, W. D., Gregoire, L., Schwartz, D. R., Cho, K. R., and Morin, P. J. (2003) Tight junction proteins claudin-3 and claudin-4 are frequently overexpressed in ovarian cancer but not in ovarian cystadenomas. Clin. Cancer Res. 9, 2567-2575 (Pubitemid 36842098)
31. Lee, J. W., Lee, S. J., Seo, J., Song, S. Y., Ahn, G., Park, C. S., Lee, J. H., Kim, B. G., and Bae, D. S. (2005) Increased expressions of claudin-1 and claudin-7 during the progression of cervical neoplasia. Gynecol. Oncol. 97, 53-59 (Pubitemid 40403674)
32. Soini, Y. (2005) Expression of claudins 1, 2, 3, 4, 5, and 7 in various types of tumors. Histopathology 46, 551-560
33. Hennessy, B. T., Gonzalez-Angulo, A. M., Stemke-Hale, K., Gilcrease, M. Z., Krishnamurthy, S., Lee, J. S., Fridlyand, J., Sahin, A., Agarwal, R., Joy, C., Liu, W., Stivers, D., Baggerly, K., Carey, M., Lluch, A., Monteagudo, C., He, X., Weigman, V., Fan, C., Palazzo, J., Hortobagyi, G. N., Nolden, L. K., Wang, N. J., Valero, V., Gray, J. W., Perou, C. M., and Mills, G. B. (2009) Characterization of a naturally occurring breast cancer subset enriched in epithelial-to-mesenchymal transition and stem cell characteristics. Cancer Res. 69, 4116-4124
34. Perou, C. M. (2011) Molecular stratification of triple-negative breast cancers. Oncologist 16, 61-70
35. Felinski, E. A., Cox, A. E., Phillips, B. E., and Antonetti, D. A. (2008) Glucocorticoids induce transactivation of tight junction genes occludin and claudin-5 in retinal endothelial cells via a novel cis-element. Exp. Eye Res. 86, 867-878
36. Qi, J., Rice, S. J., Salzberg, A. C., Runkle, E. A., Liao, J., Zander, D. S., and Mu, D. (2012) MiR-365 regulates lung cancer and developmental gene thyroid transcription factor 1. Cell Cycle 11, 177-186
37. Farré, D., Roset, R., Huerta, M., Adsuara, J. E., Roselló, L., Albà, M. M., and Messeguer, X. (2003) Identification of patterns in biological sequences at the ALGGEN server. PROMO and MALGEN. Nucleic Acids Res. 31, 3651-3653
38. Messeguer, X., Escudero, R., Farré, D., Núñez, O., Martínez, J., and Albà, M. M. (2002) PROMO. Detection of known transcription regulatory elements using species-tailored searches. Bioinformatics 18, 333-334 (Pubitemid 34183117)
39. Guazzi, S., Price, M., De Felice, M., Damante, G., Mattei, M. G., and Di Lauro, R. (1990) Thyroid nuclear factor 1 (TTF-1) contains a homeodomain and displays a novel DNA binding specificity. EMBO J. 9, 3631-3639
40. Damante, G., Fabbro, D., Pellizzari, L., Civitareale, D., Guazzi, S., Polycarpou-Schwartz, M., Cauci, S., Quadrifoglio, F., Formisano, S., and Di Lauro, R. (1994) Sequence-specific DNA recognition by the thyroid transcription factor-1 homeodomain. Nucleic Acids Res. 22, 3075-3083 (Pubitemid 24260638)
41. Fabbro, D., Tell, G., Leonardi, A., Pellizzari, L., Pucillo, C., Lonigro, R., Formisano, S., and Damante, G. (1996) In the TTF-1 homeodomain the contribution of several amino acids to DNA recognition depends on the bound sequence. Nucleic Acids Res. 24, 3283-3288 (Pubitemid 26294435)
42. Pellizzari, L., Tell, G., Fabbro, D., Pucillo, C., and Damante, G. (1997) Functional interference between contacting amino acids of homeodomains. FEBS Lett. 407, 320-324 (Pubitemid 27199451)
43. Bohinski, R. J., Di Lauro, R., and Whitsett, J. A. (1994) The lung-specific surfactant protein B gene promoter is a target for thyroid transcription factor 1 and hepatocyte nuclear factor 3, indicating common factors for organ-specific gene expression along the foregut axis. Mol. Cell. Biol. 14, 5671-5681
44. Medici, D., Hay, E. D., and Goodenough, D. A. (2006) Cooperation between snail and LEF-1 transcription factors is essential for TGF-β1-induced epithelial-mesenchymal transition. Mol. Biol. Cell 17, 1871-1879 (Pubitemid 44011602)
45. Reddel, R. R., Ke, Y., Gerwin, B. I., McMenamin, M. G., Lechner, J. F., Su, R. T., Brash, D. E., Park, J. B., Rhim, J. S., and Harris, C. C. (1988) Transformation of human bronchial epithelial cells by infection with SV40 or adenovirus-12 SV40 hybrid virus or transfection via strontium phosphate coprecipitation with a plasmid containing SV40 early region genes. Cancer Res. 48, 1904-1909
46. Hsu, D. S., Acharya, C. R., Balakumaran, B. S., Riedel, R. F., Kim, M. K., Stevenson, M., Tuchman, S., Mukherjee, S., Barry, W., Dressman, H. K., Nevins, J. R., Powers, S., Mu, D., and Potti, A. (2009) Characterizing the developmental pathways TTF-1, NKX2-8, and PAX9 in lung cancer. Proc. Natl. Acad. Sci. U.S.A. 106, 5312-5317
47. De Felice, M., Damante, G., Zannini, M., Francis-Lang, H., and Di Lauro, R. (1995) Redundant domains contribute to the transcriptional activity of the thyroid transcription factor 1. J. Biol. Chem. 270, 26649-26656
48. Hosono, Y., Yamaguchi, T., Mizutani, E., Yanagisawa, K., Arima, C., Tomida, S., Shimada, Y., Hiraoka, M., Kato, S., Yokoi, K., Suzuki, M., and Takahashi, T. (2012) MYBPH, a transcriptional target of TTF-1, inhibits ROCK1 and reduces cell motility and metastasis. EMBO J. 31, 481-493
49. Wei, L., Yang, Y., and Yu, Q. (2001) Tyrosine kinase-dependent, phosphatidylinositol 3′-kinase, and mitogen-activated protein kinase-independent signaling pathways prevent lung adenocarcinoma cells from anoikis. Cancer Res. 61, 2439-2444 (Pubitemid 32685821)
50. Kumar, S., Park, S. H., Cieply, B., Schupp, J., Killiam, E., Zhang, F., Rimm, D. L., and Frisch, S. M. (2011) A pathway for the control of anoikis sensitivity by E-cadherin and epithelial-to-mesenchymal transition. Mol. Cell. Biol. 31, 4036-4051
51. Capaldo, C. T., and Nusrat, A. (2009) Cytokine regulation of tight junctions. Biochim. Biophys. Acta 1788, 864-871
52. Martin, T. A., and Jiang, W. G. (2009) Loss of tight junction barrier function and its role in cancer metastasis. Biochim. Biophys. Acta 1788, 872-891
53. Balda, M. S., Garrett, M. D., and Matter, K. (2003) The ZO-1-associated Y-box factor ZONAB regulates epithelial cell proliferation and cell density. J. Cell Biol. 160, 423-432 (Pubitemid 36182732)
54. Sourisseau, T., Georgiadis, A., Tsapara, A., Ali, R. R., Pestell, R., Matter, K., and Balda, M. S. (2006) Regulation of PCNA and cyclin D1 expression and epithelial morphogenesis by the ZO-1-regulated transcription factor ZONAB/DbpA. Mol. Cell. Biol. 26, 2387-2398 (Pubitemid 43346937)
55. Gottardi, C. J., Arpin, M., Fanning, A. S., and Louvard, D. (1996) The junction-associated protein, zonula occludens-1, localizes to the nucleus before the maturation and during the remodeling of cell-cell contacts. Proc. Natl. Acad. Sci. U.S.A. 93, 10779-10784 (Pubitemid 26333066)
56. Damante, G., Pellizzari, L., Esposito, G., Fogolari, F., Viglino, P., Fabbro, D., Tell, G., Formisano, S., and Di Lauro, R. (1996) A molecular code dictates sequence-specific DNA recognition by homeodomains. EMBO J. 15, 4992-5000 (Pubitemid 26315809)
57. Hanes, S. D., and Brent, R. (1991) A genetic model for interaction of the homeodomain recognition helix with DNA. Science 251, 426-430 (Pubitemid 21916904)
58. Liu, H., Radisky, D. C., Yang, D., Xu, R., Radisky, E. S., Bissell, M. J., and Bishop, J. M. (2012) MYC suppresses cancer metastasis by direct transcriptional silencing of αv and β3 integrin subunits. Nat. Cell Biol. 14, 567-574
59. Vincent, T., Neve, E. P., Johnson, J. R., Kukalev, A., Rojo, F., Albanell, J., Pietras, K., Virtanen, I., Philipson, L., Leopold, P. L., Crystal, R. G., de Herreros, A. G., Moustakas, A., Pettersson, R. F., and Fuxe, J. (2009) A SNAIL1-SMAD3/4 transcriptional repressor complex promotes TGF-β-mediated epithelial-mesenchymal transition. Nat. Cell Biol. 11, 943-950